Pharmacokinetic assessment of a polymersome-based molecular beacon by in vivo fluorescence monitoring

Ulas Sunar; P. Peter Ghoroghchian; Xavier Intes; Michael J. Therien; Daniel A. Hammer; Arjun G. Yodh

doi:10.1117/12.700802

13 February 2007 Pharmacokinetic assessment of a polymersome-based molecular beacon by in vivo fluorescence monitoring

Ulas Sunar, P. Peter Ghoroghchian, Xavier Intes, Michael J. Therien, Daniel A. Hammer, Arjun G. Yodh

Proceedings Volume 6434, Optical Tomography and Spectroscopy of Tissue VII; 64342I (2007) https://doi.org/10.1117/12.700802
Event: SPIE BiOS, 2007, San Jose, California, United States

Abstract

Indocyanine Green (ICG) is currently the only FDA-approved contrast agent suitable for imaging tumor vascularity and performing permeability measurements. However, it is non-specific; clearance (wash-out) by the liver is very rapid, and tumor to normal tissue contrast is not optimal for medical imaging applications. Therefore, new ICG derivatives are being developed with improved affinity tumor cell affinity, and prolonged circulation times.¹ Furthermore, several new contrast agents (molecular beacons) with specific tumor targeting have been reported. Tumor cells over-express certain receptors which results in an increased uptake of ligands specific to those receptors. Chemical conjugation of molecular beacons to such ligands allows for accumulation of the agents specifically at tumor cites. For example, Weissleder et al.² have developed protease-activated molecular beacons that achieved a 12-fold tumor to normal tissue contrast. New molecular beacons might have direct impact on therapy monitoring: with higher sensitivity and specificity, one can noninvasively monitor and therapeutically intervene tumors in their early stages, which should lead to better survival rates.

Citation Download Citation

Ulas Sunar, P. Peter Ghoroghchian, Xavier Intes, Michael J. Therien, Daniel A. Hammer, and Arjun G. Yodh "Pharmacokinetic assessment of a polymersome-based molecular beacon by in vivo fluorescence monitoring", Proc. SPIE 6434, Optical Tomography and Spectroscopy of Tissue VII, 64342I (13 February 2007); https://doi.org/10.1117/12.700802

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available